J Allergy Clin Immunol. 1998 Oct;102(4 Pt 1):558-62.

Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper.

Source

World Health Organization.

Abstract

The World Health Organization and various allergy, asthma, and immunology societies throughout the world met on January 27 through 29, 1997, in Geneva, Switzerland to write guidelines for allergen immunotherapy. Over the ensuing year, the editors and panel members reached a consensus about the information to include in the WHO position paper "Allergen immunotherapy: Therapeutic vaccines for allergic diseases." The historical term allergen extract was changed to allergen vaccine to reflect the fact that allergen vaccines are used in medicine as immune modifiers. The document summarizes the scientific literature and rationale for the appropriate use of such therapy to treat allergic rhinoconjunctivitis, allergic asthma, and Hymenoptera hypersensitivity. It also includes recommendations to improve safety, discusses new techniques being developed that may result in better efficacy and less risk, and offers recommendations for areas of additional and necessary research.

PMID:: 9802362; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Related citations

Review [WHO position paper (summary)--allergen-immunotherapy: therapeutic vaccines for allergic diseases]. [Wien Med Wochenschr. 1999]
Review [WHO position paper (summary)--allergen-immunotherapy: therapeutic vaccines for allergic diseases].
Malling HJ. Wien Med Wochenschr. 1999; 149(14-15):410-4.
Review Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and Immunology. [Ann Allergy Asthma Immunol. 1998]
Review Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and Immunology.
Bousquet J, Lockey R, Malling HJ, Alvarez-Cuesta E, Canonica GW, Chapman MD, Creticos PJ, Dayer JM, Durham SR, Demoly P, et al. Ann Allergy Asthma Immunol. 1998 Nov; 81(5 Pt 1):401-5.
Review GA² LEN/EAACI pocket guide for allergen-specific immunotherapy for allergic rhinitis and asthma. [Allergy. 2010]
Review GA² LEN/EAACI pocket guide for allergen-specific immunotherapy for allergic rhinitis and asthma.
Zuberbier T, Bachert C, Bousquet PJ, Passalacqua G, Walter Canonica G, Merk H, Worm M, Wahn U, Bousquet J. Allergy. 2010 Dec; 65(12):1525-30. Epub 2010 Sep 7.
Review [Evaluation of the pediatric aspects of the WHO document and meta-analysis of immunotherapy]. [Allergol Immunopathol (Madr). 2000]
Review [Evaluation of the pediatric aspects of the WHO document and meta-analysis of immunotherapy].
Ibáñez Sendín MD. Allergol Immunopathol (Madr). 2000 May-Jun; 28(3):82-9.
Review Guidelines for the use of allergen immunotherapy. Canadian Society of Allergy and Clinical Immunology. [CMAJ. 1995]
Review Guidelines for the use of allergen immunotherapy. Canadian Society of Allergy and Clinical Immunology.
. CMAJ. 1995 May 1; 152(9):1413-9.

See reviews... See all...

Cited by 27 PubMed Central articles

Treatment of severe atopic dermatitis with a combination of subcutaneous allergen immunotherapy and cyclosporin. [Yonsei Med J. 2012]
Treatment of severe atopic dermatitis with a combination of subcutaneous allergen immunotherapy and cyclosporin.
Nahm DH, Kim ME. Yonsei Med J. 2012 Jan; 53(1):158-63.
Lipid nanoparticles as delivery vehicles for the Parietaria judaica major allergen Par j 2. [Int J Nanomedicine. 2011]
Lipid nanoparticles as delivery vehicles for the Parietaria judaica major allergen Par j 2.
Bondì ML, Montana G, Craparo EF, Di Gesù R, Giammona G, Bonura A, Colombo P. Int J Nanomedicine. 2011; 6:2953-62. Epub 2011 Nov 21.
Induction of tolerance via the sublingual route: mechanisms and applications. [Clin Dev Immunol. 2012]
Induction of tolerance via the sublingual route: mechanisms and applications.
Moingeon P, Mascarell L. Clin Dev Immunol. 2012; 2012:623474. Epub 2011 Nov 10.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO positi...
Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper.
J Allergy Clin Immunol. 1998 Oct ;102(4 Pt 1):558-62.

PubMed
Lymphoepithelioma-like carcinoma of the breast.
Lymphoepithelioma-like carcinoma of the breast.
Mod Pathol. 1994 Jan ;7(1):129-31.

PubMed
Increasing the impact of quality improvement on health: an expert panel method f...
Increasing the impact of quality improvement on health: an expert panel method for setting institutional priorities.
Jt Comm J Qual Improv. 1995 Aug ;21(8):420-32.

PubMed
Resident and family continuity in pediatric continuity clinic: nine years of obs...
Resident and family continuity in pediatric continuity clinic: nine years of observation.
Pediatrics. 1998 Jan ;101(1 Pt 1):37-42.

PubMed
Frequent oligonucleotides and peptides of the Haemophilus influenzae genome.
Frequent oligonucleotides and peptides of the Haemophilus influenzae genome.
Nucleic Acids Res. 1996 Nov 1 ;24(21):4263-72.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: